{
    "clinical_study": {
        "@rank": "151236", 
        "arm_group": {
            "arm_group_label": "Cohort 1", 
            "description": "Cohort 1"
        }, 
        "brief_summary": {
            "textblock": "This study was designed to evaluate the effectiveness, safety; impact on quality of life\n      related to health and depressive symptoms when paricalcitol is administered in Venezuelan\n      patients on hemodialysis, and who are on risk to develop secondary hyperparathyroidism\n      associated, with stage V chronic kidney disease.\n\n      Through this observational, multicenter, non interventional study it will be possible to\n      obtain data that will help to improve the better understanding of the clinical conditions of\n      these patients who are on risk to develop secondary hyperparathyroidism, due to chronic\n      kidney disease stage V and that are receiving hemodialysis, as well as the safety profile of\n      the product through the experience with local population. Additionally, it will be obtained\n      quantifiable information of impact on the quality of life related to health and depressive\n      symptoms of patients, from theirs perspective."
        }, 
        "brief_title": "Post Marketing Observational Study on Paricalcitol IV Administered to Venezuelan Patients", 
        "completion_date": {
            "#text": "October 2014", 
            "@type": "Anticipated"
        }, 
        "condition": [
            "Chronic Kidney Disease Stage V", 
            "Hemodialysis"
        ], 
        "condition_browse": {
            "mesh_term": [
                "Kidney Diseases", 
                "Renal Insufficiency, Chronic", 
                "Kidney Failure, Chronic"
            ]
        }, 
        "eligibility": {
            "criteria": {
                "textblock": "Inclusion Criteria:\n\n          -  Male or female \u2265 18 years old with documented diagnosis of stage V chronic kidney\n             disease, on hemodialysis at study baseline\n\n          -  Subjects who have been previously treated with vitamin D or its metabolites or na\u00efve\n             to paricalcitol\n\n          -  Subjects in whom the use of paricalcitol is clinically indicated and documented by\n             applicable and routine standard of healthcare (i.e. laboratory assessments and\n             clinical evaluations) according to the criteria of the attending physician and in\n             accordance with the approved label of the product in Venezuela\n\n          -  Subjects that provide written informed consent form stating his/her authorization and\n             willingness to participate in the study and allowing the use and discussion of\n             his/her personal and/or health information before entering the study\n\n          -  Female subjects with reproductive potential must use an approved contraceptive method\n             (IUD, birth control pills or barrier device) during and for three (03) months after\n             discontinuation of treatment\n\n        Exclusion Criteria:\n\n          -  Subjects with severe hyperparathyroidism (PTH> 3000 pg / mL)\n\n          -  Subjects with hypercalcemia, adjusted according to serum albumin, hyperphosphatemia,\n             or subjects with calcium-phosphorus product (Ca x P) \u2265 70\n\n          -  Known hypersensitivity and/or toxicity of vitamin D, its metabolites and/or other\n             components of Zemplar\u00ae IV (paricalcitol)\n\n          -  Subjects who have participated in clinical trials within 30 days before the start of\n             the study or who are currently enrolled in a clinical trial or under treatment with\n             any investigational product\n\n          -  Subjects who cannot tolerate or cannot take phosphate binders that do not contain\n             calcium and/or aluminum\n\n          -  Subjects who in the opinion of the investigator, for any reason (including medical\n             reasons) are not eligible and/or appropriate for therapy with synthetic analogs of\n             vitamin D and/or unwilling to complete the study visits"
            }, 
            "gender": "Both", 
            "healthy_volunteers": "No", 
            "maximum_age": "N/A", 
            "minimum_age": "18 Years", 
            "sampling_method": "Probability Sample", 
            "study_pop": {
                "textblock": "Subjects with diagnosis of Chronic Kidney Disease Stage V undergoing Hemodialysis"
            }
        }, 
        "enrollment": {
            "#text": "420", 
            "@type": "Anticipated"
        }, 
        "firstreceived_date": "December 27, 2012", 
        "has_expanded_access": "No", 
        "id_info": {
            "nct_id": "NCT01758289", 
            "org_study_id": "P13-785"
        }, 
        "is_fda_regulated": "No", 
        "keyword": [
            "Venezuelan Patients", 
            "Depressive Symptoms", 
            "Health Related Quality of Life"
        ], 
        "lastchanged_date": "March 20, 2014", 
        "link": {
            "url": "http://rxabbott.com/u4_prescribing_info.cfm."
        }, 
        "location": [
            {
                "facility": {
                    "address": {
                        "city": "Acarigua", 
                        "country": "Venezuela"
                    }, 
                    "name": "Site Reference ID/Investigator# 96757"
                }
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Anaco", 
                        "country": "Venezuela"
                    }, 
                    "name": "Site Reference ID/Investigator# 96764"
                }
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Aragua", 
                        "country": "Venezuela"
                    }, 
                    "name": "Site Reference ID/Investigator# 96769"
                }
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Barquisimeto", 
                        "country": "Venezuela"
                    }, 
                    "name": "Site Reference ID/Investigator# 96766"
                }
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Cabimas", 
                        "country": "Venezuela"
                    }, 
                    "name": "Site Reference ID/Investigator# 96756"
                }
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Caracas", 
                        "country": "Venezuela"
                    }, 
                    "name": "Site Reference ID/Investigator# 96755"
                }
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Caracas", 
                        "country": "Venezuela"
                    }, 
                    "name": "Site Reference ID/Investigator# 96768"
                }
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Caracas", 
                        "country": "Venezuela"
                    }, 
                    "name": "Site Reference ID/Investigator# 96759"
                }
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Caracas", 
                        "country": "Venezuela"
                    }, 
                    "name": "Site Reference ID/Investigator# 96772"
                }
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Maracaibo", 
                        "country": "Venezuela"
                    }, 
                    "name": "Site Reference ID/Investigator# 96761"
                }
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Maracaibo", 
                        "country": "Venezuela"
                    }, 
                    "name": "Site Reference ID/Investigator# 96771"
                }
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Maracaibo", 
                        "country": "Venezuela"
                    }, 
                    "name": "Site Reference ID/Investigator# 96760"
                }
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Maracaibo", 
                        "country": "Venezuela"
                    }, 
                    "name": "Site Reference ID/Investigator# 96758"
                }
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Merida", 
                        "country": "Venezuela"
                    }, 
                    "name": "Site Reference ID/Investigator# 96762"
                }
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Miranda", 
                        "country": "Venezuela"
                    }, 
                    "name": "Site Reference ID/Investigator# 96770"
                }
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Monagas", 
                        "country": "Venezuela"
                    }, 
                    "name": "Site Reference ID/Investigator# 96763"
                }
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Naguanagua", 
                        "country": "Venezuela"
                    }, 
                    "name": "Site Reference ID/Investigator# 96765"
                }
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Punto Fijo", 
                        "country": "Venezuela"
                    }, 
                    "name": "Site Reference ID/Investigator# 96767"
                }
            }
        ], 
        "location_countries": {
            "country": "Venezuela"
        }, 
        "number_of_groups": "1", 
        "official_title": "A Prospective, Multicenter, Six-Month Study on the Effectiveness, Safety and Impact on Health Related Quality of Life (HRQoL) and Depression Symptoms of Paricalcitol Administered to Venezuelan Patients With Chronic Kidney Disease (Stage V) Who Are on Hemodialysis", 
        "overall_official": {
            "affiliation": "Abbott", 
            "last_name": "Juan  F Semeco, MD", 
            "role": "Study Chair"
        }, 
        "overall_status": "Suspended", 
        "oversight_info": {
            "authority": "Venezuela: Ethics Committee", 
            "has_dmc": "No"
        }, 
        "phase": "N/A", 
        "primary_completion_date": {
            "#text": "October 2014", 
            "@type": "Anticipated"
        }, 
        "primary_outcome": {
            "description": "Proportion of patients achieving at least a 30% reduction in the levels of PTH from baseline compared with values in the final study visit, after a period of six (6) months of paricalcitol administration", 
            "measure": "Proportion of patients achieving at least a 30% reduction in the levels of PTH from baseline compared with values in the final study visit", 
            "safety_issue": "No", 
            "time_frame": "Six Months (24 weeks) from baseline to final visit"
        }, 
        "required_header": {
            "download_date": "ClinicalTrials.gov processed this data on June 04, 2014", 
            "link_text": "Link to the current ClinicalTrials.gov record.", 
            "url": "http://clinicaltrials.gov/show/NCT01758289"
        }, 
        "responsible_party": {
            "responsible_party_type": "Sponsor"
        }, 
        "secondary_outcome": [
            {
                "description": "Number of episodes of hypercalcemia, hyperphosphatemia and elevations of calcium-phosphate product (Ca x P)", 
                "measure": "Number of episodes of hypercalcemia, hyperphosphatemia and elevations of calcium-phosphate product (Ca x P) registered", 
                "safety_issue": "Yes", 
                "time_frame": "From baseline week 0 (first paricalcitol dose) to final study visit week 24"
            }, 
            {
                "description": "Number, proportion of subjects achieving PTH values less than 300 pg/ml", 
                "measure": "Number of subjects achieving a level <300 pg/mL of PTH.", 
                "safety_issue": "No", 
                "time_frame": "From baseline (week 0) to final study visit (week 24)"
            }, 
            {
                "description": "Time require to achieve a reduction in PTH levels below <300 pg/mL", 
                "measure": "Time require to achieve a reduction in PTH levels below <300 pg/mL, or a reduction of 30%, or both compared with the baseline.", 
                "safety_issue": "No", 
                "time_frame": "From baseline (week 0) to final study visit (week 24)"
            }, 
            {
                "description": "Changes in HRQoL EQ-5D questionnaire", 
                "measure": "Changes in HRQoL EQ-5D questionnaire parameters, according the score from baseline to final visit.", 
                "safety_issue": "No", 
                "time_frame": "From baseline (week 0) to final study visit (week 24)"
            }, 
            {
                "description": "Changes and prevalence of depressive symptoms measured by Beck's Depression Inventory", 
                "measure": "Changes in Beck's Depression Inventory", 
                "safety_issue": "No", 
                "time_frame": "From baseline (week 0) to final study visit (week 24)"
            }
        ], 
        "source": "AbbVie", 
        "sponsors": {
            "lead_sponsor": {
                "agency": "Abbott (Venezuela)", 
                "agency_class": "Industry"
            }
        }, 
        "start_date": "January 2013", 
        "study_design": "Observational Model: Cohort, Time Perspective: Prospective", 
        "study_type": "Observational", 
        "verification_date": "March 2014", 
        "why_stopped": "Delayed"
    }
}